Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,152,973
-
Share change
-
+7,152,973
-
Total reported value
-
$77,558,000
-
Price per share
-
$10.88
-
Number of holders
-
18
-
Value change
-
+$77,558,000
-
Number of buys
-
18
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q3 2018
As of 30 Sep 2018,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,152,973 shares.
The largest 10 holders included
Novo Holdings A/S, FRAZIER MANAGEMENT LLC, Sofinnova Ventures Inc, TPG Group Holdings (SBS) Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, LUMINUS MANAGEMENT LLC, Hound Partners, LLC, MILLENNIUM MANAGEMENT LLC, CREDIT SUISSE AG/, and GOLDMAN SACHS GROUP INC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.